Clinical management of autoimmune hepatitis

Clinical management of autoimmune hepatitis

Autoimmune hepatitis is a rare and chronic liver disease that is characterised by increased serum transaminases and immunoglobulin G, inflammatory liver histology and presence of circulating autoantibodies. An autoimmune hepatitis diagnosis justifies life-long treatment in most patients in order to...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Simon Pape, Christoph Schramm, Tom J.G. Gevers
Hōputu:	Revisão
Reo:	Ingarihi
I whakaputaina:	2019
Urunga tuihono:	https://doi.org/10.1177/2050640619872408 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1177/2050640619872408
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

Clinical management of autoimmune hepatitis
mā: Pape, Simon, me ētahi atu.
I whakaputaina: (2019)

Health-related quality of life in autoimmune hepatitis
mā: Snijders, Romée JALM, me ētahi atu.
I whakaputaina: (2021)

Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis
mā: Simon Pape, me ētahi atu.
I whakaputaina: (2019)

Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months
mā: Simon Pape, me ētahi atu.
I whakaputaina: (2019)

Evaluation of hepatic cystic lesions
mā: Lantinga, Marten A, me ētahi atu.
I whakaputaina: (2013)

Autoimmune Hepatitis Beyond Steroids: Effective Trial Design and Attention to Quality of Life
mā: Schramm, Christoph
I whakaputaina: (2019)

High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation
mā: Pape, Simon, me ētahi atu.
I whakaputaina: (2020)

Drug induced liver injury and its relationship to autoimmune hepatitis
mā: Christina Weiler‐Normann, me ētahi atu.
I whakaputaina: (2011)

Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
mā: Nwe Ni Than, me ētahi atu.
I whakaputaina: (2019)

Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
mā: Than, Nwe Ni, me ētahi atu.
I whakaputaina: (2019)

Clinical features and management of autoimmune hepatitis
mā: Krawitt, Edward L
I whakaputaina: (2008)

Diagnosis and management of autoimmune hepatitis
mā: Michael P. Manns, me ētahi atu.
I whakaputaina: (2010)

Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group
mā: Simon Pape, me ētahi atu.
I whakaputaina: (2022)

Autoimmune Hepatitis and Overlap Syndromes: Diagnosis and Management
mā: Simon C. Ling
I whakaputaina: (2015)

Expert clinical management of autoimmune hepatitis in the real world
mā: Rodrigo Liberal, me ētahi atu.
I whakaputaina: (2016)

Diagnosis and management of autoimmune hepatitis
mā: Luigi Muratori, me ētahi atu.
I whakaputaina: (2023)

Autoimmune hepatitis and complexities in management
mā: Janmohamed, Ashnila, me ētahi atu.
I whakaputaina: (2019)

Management of Autoimmune Hepatitis in Pregnant Women
mā: Peters, Marion G.
I whakaputaina: (2017)

Management and outcome of pregnancy in autoimmune hepatitis
mā: Michael A. Heneghan, me ētahi atu.
I whakaputaina: (2001)

Autoantibodies in Autoimmune Liver Disease—Clinical and Diagnostic Relevance
mā: Marcial Sebode, me ētahi atu.
I whakaputaina: (2018)

Autoantibodies in Autoimmune Liver Disease—Clinical and Diagnostic Relevance
mā: Sebode, Marcial, me ētahi atu.
I whakaputaina: (2018)

Challenges in the diagnosis and management of autoimmune hepatitis
mā: Czaja, Albert J
I whakaputaina: (2013)

Aspiration sclerotherapy combined with pasireotide to improve reduction of large symptomatic hepatic cysts (SCLEROCYST): study protocol for a randomized controlled trial
mā: Wijnands, Titus FM, me ētahi atu.
I whakaputaina: (2015)

Management and outcome of pregnancy in autoimmune hepatitis
mā: Heneghan, M, me ētahi atu.
I whakaputaina: (2001)

A disease-specific decline of the relative abundance of<i>Bifidobacterium</i>in patients with autoimmune hepatitis
mā: Timur Liwinski, me ētahi atu.
I whakaputaina: (2020)

Autoimmune hepatitis and COVID-19: No increased risk for AIH after vaccination but reduced care
mā: Rüther, Darius Ferenc, me ētahi atu.
I whakaputaina: (2022)

Simplified criteria for the diagnosis of autoimmune hepatitis
mā: Elke Hennes, me ētahi atu.
I whakaputaina: (2008)

Recent updates on the management of autoimmune hepatitis
mā: Atsumasa Komori
I whakaputaina: (2020)

Management of patients with difficult autoimmune hepatitis
mā: Parker, Richard, me ētahi atu.
I whakaputaina: (2012)

Management of Difficult Cases of Autoimmune Hepatitis
mā: Lammert, Craig, me ētahi atu.
I whakaputaina: (2016)

Recent updates on the management of autoimmune hepatitis
mā: Komori, Atsumasa
I whakaputaina: (2021)

Acute hepatitis after COVID-19 vaccine: case series by the International autoimmune hepatitis group (IAIHG) and the european reference network on hepatological diseases (ERN RARE-LIVER)
mā: Codoni, Greta, me ētahi atu.
I whakaputaina: (2022)

Tolerance and autoimmunity in the liver
mā: Schramm, Christoph, me ētahi atu.
I whakaputaina: (2022)

Diagnosis and Management of the Overlap Syndromes of Autoimmune Hepatitis
mā: Albert J. Czaja
I whakaputaina: (2013)

Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience
mā: Pape, Simon, me ētahi atu.
I whakaputaina: (2020)

Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis
mā: Albert J. Czaja, me ētahi atu.
I whakaputaina: (2010)

Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis
mā: Laschtowitz, Alena, me ētahi atu.
I whakaputaina: (2021)

Diagnosis and management of the overlap syndromes of autoimmune hepatitis
mā: Czaja, Albert J
I whakaputaina: (2013)

Autoimmune hepatitis: Clinical challenges
mā: Michael P. Manns, me ētahi atu.
I whakaputaina: (2001)

Ultrasound findings in autoimmune hepatitis
mā: Dong, Yi, me ētahi atu.
I whakaputaina: (2018)